ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0796

Deciphering Synovial Fluid Immune Dysregulation in Rheumatoid Arthritis through Cytokine Profiling and Single-Cell Transcriptomics

Manon LESTURGIE-TALAREK1, Francesco Carbone2, Virginie Gonzalez3, Adrien Schvartz2, Sophie Hecquet4, Fiona Oudart5, Marion Thomas6, Roberto D'Alessandro7, Yannick Allanore8, Mickael Menager2 and Jérôme AVOUAC9, 1Paris University, Paris, France, 2Institut Imagine, Paris, 3INSERMU1016, Paris, France, 4Cochin Hospital, Paris, France, 5APHP - Cochin hospital, Paris, France, 6APHP, Paris, France, 7Cochin Hospital, Paris, 8Université Paris Cité, Paris, France, 9Rheumatology department, Cochin hospital, Paris, France

Meeting: ACR Convergence 2025

Keywords: cytokines, immunology, Inflammation, Interleukins, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: Abstracts: Rheumatoid Arthritis – Etiology and Pathogenesis (0795–0800)

Session Type: Abstract Session

Session Time: 1:15PM-1:30PM

Background/Purpose: Rheumatoid arthritis (RA) is driven by complex inflammatory pathways involving immune cell infiltration into synovial tissue and fluid. Synovial fluid (SF) provides direct insight into local disease mechanisms. Few studies have applied multiplex or single-cell transcriptomic technologies to dissect its cytokine and cellular composition. The objective was to (1) characterize the cytokine profile of SF in RA vs other chronic inflammatory rheumatic diseases (CIRD) and osteoarthritis (OA); (2) compare SF and serum cytokines in RA; (3) explore the single-cell transcriptomic signature of RA SF mononuclear cells (SFMCs) vs. peripheral blood mononuclear cells (PBMCs).

Methods: SF samples from 115 patients (45 RA, 48 CIRD, 22 OA) were analyzed using Luminex (21 cytokines including TNF-α, IL-1β, IL-6, IL-17, GM-CSF, IL-23, and CCL20). Paired serum samples were available for 29 RA patients. scRNA-seq was performed on freshly isolated SFMCs and PBMCs from six RA patients using 10X Chromium and CellRanger pipelines. Unsupervised clustering and differential expression analyses were used to define cellular subpopulations and compare their distribution.

Results: RA SF showed significantly higher levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-17, Granzyme B, CCL20) than OA (Fig.1A). IL-8, CCL2, and CCL3 were also elevated compared to CIRD. In RA, cytokines were consistently higher in SF than in serum and strongly correlated with CRP and DAS28-CRP, while no significant correlations were observed in serum (Fig. 1B). Heatmap analysis identified two distinct cytokine profiles in RA SF: one characterized by high cytokine secretion and elevated leukocyte count and CRP, and another with lower or moderate cytokine levels, reflecting heterogeneity in local inflammatory responses among RA patients.scRNA-seq identified 27 immune cell clusters: 7 myeloid, 20 lymphoid (Fig. 2A). SFMCs were enriched in conventional (FC = 3.5) and plasmacytoid dendritic cells (FC = 5.5), and depleted in naïve B and T cell subsets, including CD4+ and CD8+ T cells (Fig. 2B). A distinct CD4+ T cell subset expressing PD-1, IL-17, Granzyme A, and IFN-γ was identified in SFMCs, indicating a pro-inflammatory phenotype. Regulatory T cells were enriched, while cytotoxic and effector memory CD8+ T cells were reduced (Fig. 2B).

Conclusion: RA SF exhibits a compartmentalized immune response characterized by cytokine enrichment and effector cell activation. Elevated levels of CCL20, CCL2, CCL3, and CCL8 may support dendritic cell and effector T cell recruitment into the joint. Despite this chemotactic environment, naïve T cells were markedly depleted, suggesting selective homing or local maturation. Increased IL-17 and Granzyme B at both protein and transcript levels were consistent with the presence of an inflammatory CD4+ T cell cluster co-expressing IL17A, GZMA, and PRF1. These findings reveal a coordinated inflammatory network in RA synovium, linking chemokine-mediated recruitment to local T cell activation, and highlight potential therapeutic targets identified through integrated cytokine and single-cell analysis.

Supporting image 1Figure1. Cytokine profiles and correlations with clinical and biological parameters in RA. (A) Radar plot illustrating the relative concentrations of 21 cytokines in synovial fluid (SF) from rheumatoid arthritis (RA, blue), other chronic inflammatory rheumatic diseases (CIR, yellow), and osteoarthritis (OA, orange). Each axis represents a specific cytokine, with values normalized to highlight differences between disease groups. (B) Correlation matrix (corrplot) between cytokines measured in blood and various clinical and biological parameters in RA patients. (C) Correlation matrix (corrplot) between cytokines measured in blood and various clinical and biological parameters in RA patients.

Only significant Spearman correlation coefficients are represented by the intensity of the colour and the size of the square. Red: positive correlation. Blue: negative correlation. The boxed area highlights strong correlations between cytokines and markers of clinical disease activity, including CRP, DAS28-CRP, and patient-reported pain (VAS).

ACPA: Anti-citrullinated protein antibodies. CRP: C-reactive protein. DAS28: Disease Activity Score in 28 joints. ESR: Erythrocyte sedimentation rate. VAS: Visual Analog Scale. TNF-α: Tumor Necrosis Factor-alpha. IL: Interleukin. CXCL/CCL: Chemokines.

Supporting image 2Figure 2. Immune cell composition in peripheral blood and synovial fluid of rheumatoid arthritis patients (A) Uniform Manifold Approximation and Projection (UMAP) visualization of immune cell populations from peripheral blood mononuclear cells (PBMCs) and synovial fluid mononuclear cells (SFMCs) of patients with rheumatoid arthritis. Distinct cell populations are annotated based on marker expression, including dendritic cells (pDC, cDC), B cells (naive, memory), T cells (CD4-naive, CD8-naive, CD8-effector, CD8-cytotoxic, regulatory T cells, Tregs), MAIT cells, and others. (B) Boxplots showing the proportions of specific immune cell subsets in PBMCs versus SFMCs. Cell subsets analyzed include pDC, cDC, naive B cells, naive CD4 T cells, naive CD8 T cells, CD8 effector memory T cells, CD8 cytotoxic T cells, and regulatory T cells.

Significant differences between PBMCs and SFMCs are indicated by an asterisk (*).

PBMCs: Peripheral blood mononuclear cells. SFMCs: Synovial fluid mononuclear cells. pDC: Plasmacytoid dendritic cells. cDC: Conventional dendritic cells. Tregs: Regulatory T cells. MAIT: Mucosal-associated invariant T cells. UMAP: Uniform Manifold Approximation and Projection


Disclosures: M. LESTURGIE-TALAREK: None; F. Carbone: None; V. Gonzalez: None; A. Schvartz: None; S. Hecquet: None; F. Oudart: None; M. Thomas: None; R. D'Alessandro: None; Y. Allanore: None; M. Menager: None; J. AVOUAC: None.

To cite this abstract in AMA style:

LESTURGIE-TALAREK M, Carbone F, Gonzalez V, Schvartz A, Hecquet S, Oudart F, Thomas M, D'Alessandro R, Allanore Y, Menager M, AVOUAC J. Deciphering Synovial Fluid Immune Dysregulation in Rheumatoid Arthritis through Cytokine Profiling and Single-Cell Transcriptomics [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/deciphering-synovial-fluid-immune-dysregulation-in-rheumatoid-arthritis-through-cytokine-profiling-and-single-cell-transcriptomics/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deciphering-synovial-fluid-immune-dysregulation-in-rheumatoid-arthritis-through-cytokine-profiling-and-single-cell-transcriptomics/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology